Global Peptic Ulcer Market to Hit $5.15 Billion by 2030 at 4.3% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Peptic Ulcer Market Over The 2026–2030 Period?

The peptic ulcer market size has shown consistent expansion in recent years. It is anticipated to grow from $4.22 billion in 2025 to $4.35 billion in 2026, at a compound annual growth rate (CAGR) of 3.3%. This historic growth can be attributed to several factors including the high prevalence of h. pylori infections, insufficient awareness of peptic ulcer complications, the extensive use of NSAIDs, reliance on traditional symptomatic treatments, and inadequate early diagnosis.

The peptic ulcer market size is anticipated to experience consistent expansion over the upcoming years. This market is projected to reach $5.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.3%. Several factors are driving this anticipated growth, including a greater embrace of proton pump inhibitors and antibiotics, an increase in hospital and private clinic treatment infrastructure, heightened understanding of preventive health measures, advancements in non-invasive diagnostic methods, and the broadening of e-commerce and retail pharmacy distribution networks. Key developments expected during this timeframe involve the increasing implementation of AI-powered diagnostic instruments, customized ulcer therapies informed by genomics, the application of cloud and big data technologies for patient oversight, the incorporation of IoT devices for distant symptom observation, and sophisticated production techniques for ulcer treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

What Primary Drivers Are Shaping The Peptic Ulcer Market?

The increasing occurrence of obesity is projected to boost the expansion of the peptic ulcer market moving forward. Obesity is defined as a medical state marked by an excessive build-up of body fat, usually leading to a body mass index (BMI) of 30 or higher. This condition can stem from genetic, environmental, and lifestyle elements, including an unhealthy diet and insufficient physical activity. It causes the stomach to produce too much acid, impairs the stomach’s defensive mucosal layer, and fosters the formation of peptic ulcers. Furthermore, extra weight appears to trigger inflammation in the digestive system, which can result in the development of peptic ulcers. For example, in May 2025, the World Health Organization, a Switzerland-based intergovernmental international organization, announced that in 2024, 35 million children under the age of 5 were overweight. Consequently, the rising incidence of obesity is propelling the expansion of the peptic ulcer market.

What Are The Different Segment Types In The Peptic Ulcer Market Segment Breakdown?

The peptic ulcer market covered in this report is segmented –

1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)

2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs

3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce

Subsegments:

1) By Gastritis: Acute Gastritis, Chronic Gastritis

2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer

3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer

4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD

What Trends Are Affecting The Growth Of The Peptic Ulcer Market?

Key companies operating in the peptic ulcer market are prioritizing the development of innovative solutions, such as combination therapy drug kits, to satisfy the increasing need for effective H. pylori eradication and ulcer management. These combination therapy kits combine multiple active ingredients within a single regimen, which enhances treatment adherence and provides a more targeted approach than conventional single-drug therapies. For instance, in April 2023, Akums Drugs and Pharmaceuticals Ltd., an India-based company specializing in pharmaceutical formulations and APIs, launched Combikit, an advanced three-drug formulation. The Combikit includes amoxicillin, clarithromycin, and esomeprazole, formulated to simultaneously address bacterial elimination, acid suppression, and the healing of ulcers. It obtained approval from the Central Drugs Standard Control Organisation (CDSCO) for addressing duodenal ulcers linked to Helicobacter pylori (H. pylori) and for eradicating H. pylori in patients with either active or healed peptic ulcers. By integrating complementary mechanisms of action, the kit improves treatment efficacy, diminishes ulcer recurrence, and boosts patient compliance, especially in areas with a high prevalence of H. pylori.

Who Are The Well-Known Companies In The Peptic Ulcer Market?

Major companies operating in the peptic ulcer market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Get The Full Peptic Ulcer Market Report:

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Which Region Is The Largest In The Peptic Ulcer Market?

North America was the largest region in the peptic ulcer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Peptic Ulcer Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Browse Through More Reports Similar to the Global Peptic Ulcer Market 2026, By The Business Research Company

Robotic Prosthetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/robotic-prosthetics-global-market-report

Orthopedic Prosthetics Market Report

https://www.thebusinessresearchcompany.com/report/orthopedic-prosthetics-global-market-report

Prosthetics And Orthotics Market Report

https://www.thebusinessresearchcompany.com/report/prosthetics-and-orthotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795